1
Have a requirement?
Chat with us
1
Have a requirement?
Chat with us
Cipla was established in 1935 with the vision of making India self-reliant and self-sufficient in healthcare. Today, we are one of the world’s largest generic pharmaceutical companies with a presence in over 170 countries. We are renowned for making affordable, world-class medicines that meet the needs of patients across therapies. We also offer services like consulting, commissioning, plant engineering, technical know-how transfer and support.
Incorporated1935Corporate OfficeCipla Ltd., Mumbai Central, Mumbai 400 008, IndiaChairmanDr. Yusuf K. HamiedExecutive Vice-ChairmanMr. M.K. HamiedListingEquity Shares: BSE Limited and National Stock Exchange of India Limited Global Depository Receipts: Luxembourg Stock ExchangeTurnover*USD 1.5 billionEmployees*20,000ApprovalsUS FDA, WHO-Geneva, MHRA-UK, TGA-Australia, SUKL-Slovak Republic, APVMA-Australia, MCC-South Africa, PIC-Germany, Danish Medical Agency, ANVISA-Brazil, INVIMA- Colombia, NDA-Uganda, Department of Health-Canada and MOH-Saudi Arabia, among othersHighlightsOne of the world’s largest generic companies.Over 2,000 products, 65 therapeutic categories, over 40 dosage forms.34 state-of-the-art manufacturing facilities approved by major international regulatory agencies.Continuous innovation in R&D; over 20 world firsts.Contactcontactus@cipla.com+91 22 23082891, +91 22 23095521 + Read More
Incorporated1935Corporate OfficeCipla Ltd., Mumbai Central, Mumbai 400 008, IndiaChairmanDr. Yusuf K. HamiedExecutive Vice-ChairmanMr. M.K. HamiedListingEquity Shares: BSE Limited and National Stock Exchange of India Limited Global Depository Receipts: Luxembourg Stock ExchangeTurnover*USD 1.5 billionEmployees*20,000ApprovalsUS FDA, WHO-Geneva, MHRA-UK, TGA-Australia, SUKL-Slovak Republic, APVMA-Australia, MCC-South Africa, PIC-Germany, Danish Medical Agency, ANVISA-Brazil, INVIMA- Colombia, NDA-Uganda, Department of Health-Canada and MOH-Saudi Arabia, among othersHighlightsOne of the world’s largest generic companies.Over 2,000 products, 65 therapeutic categories, over 40 dosage forms.34 state-of-the-art manufacturing facilities approved by major international regulatory agencies.Continuous innovation in R&D; over 20 world firsts.Contactcontactus@cipla.com+91 22 23082891, +91 22 23095521 + Read More
Nature of Business
ManufacturerLegal Status of Firm
Limited CompanyAnnual Turnover
> 500 CrGST Registration Date
01-07-2017GST Number
27AAACC1450B1ZE
HSN CodeHSN Description
33049990Beauty or make-up preparations and preparations for the care of the skin (other than medicaments), including sunscreen or suntan preparations; manicure or pedicure preparations other: other other
9019209020 mechano-therapy appliances; massage apparatus; psychological aptitude-testing apparatus; ozone therapy, oxygen therapy, aerosol therapy, artificial respiration or other therapeutic respiration apparatus- ozone therapy, oxygen therapy, aerosol therapy, artificial respiration or other therapeutic respiration apparatus: other
21069099Food preparations not elsewhere specified or included - other : other : other
29420090Other organic compounds - other organic compounds : other
30049099Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale other : other : other
Tell us what you need, and we’ll help you get quotes
Tell us what you
need
need
Receive seller
details
details
Seal the deal
Pay with IndiaMART
Tell us what you need, and we’ll help you get quotes